Texas State Representative
J.D. Sheffield 2015 - 84th Regular - Authored & Sponsored Legislation (Page 11)
Legislative Session
Sponsor of Legislation
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB277
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to certain health-related and other task forces and advisory committees.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB378
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the liability of certain social workers who provide volunteer health care services to charitable organizations.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB42
Filed
11/10/14
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the selection process for student members of the board of regents of a state university or state university system.
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB570
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the use of fireworks at certain Texas Department of Transportation rest areas; creating a criminal offense.
Joint Sponsor of Legislation
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB339
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to the medical use of low-THC cannabis and the regulation of related organizations and individuals; requiring a dispensing organization to obtain a license to dispense low-THC cannabis and any employee of a dispensing organization to obtain a registration; authorizing fees.
Co-Sponsor of Legislation
TX
Texas 2015 - 84th Regular
Texas Senate Bill SB694
Filed
Out of Senate Committee
Voted on by Senate
Out of House Committee
Voted on by House
Governor Action
Bill Becomes Law
Relating to authorizing patients with certain terminal illnesses to access certain investigational drugs, biological products, and devices that are in clinical trials.